Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials
Crossref DOI link: https://doi.org/10.1186/s12916-014-0132-3
Published Online: 2014-08-12
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lavaud, Pernelle
Andre, Fabrice
License valid from 2014-08-12